Company Info
Phone(857) 400-9491
Year Established
2017
Ticker
THRX
Exchange
NASDAQ
Contacts
Kristine Callahan, CPAVice President, Controller
Brad Dahms
President & CFO
Company Description
Theseus Pharmaceuticals is developing pan-variant tyrosine kinase inhibitors (TKIs) designed to overcome treatment-resistant cancer mutations.
